Brwned
Have you ever been in love before?
- Joined
- Apr 18, 2008
- Messages
- 50,937
BAME covid19 issues in UK are sociological and not biological or genetic? So surely this isn't really an issue?
That is more of a political point than a medical one. We don't know - in a scientific sense - what the causes of these differences are. There's still a lot we don't know know about the virus. We just know those differences are so large that it would be very dangerous to not account for. We know there are some socioeconomic influences but we also have reason to belief there are biological (not necessarily genetic) influences too. Which is why the FDA specifically mentioned ethnic minorities as a group to pay special attention to, much like elderly individuals and pregnant women, in their guidelines for vaccine development.
FDA encourages the inclusion of diverse populations in all phases of vaccine clinical development. This inclusion helps to ensure that vaccines are safe and effective for everyone in the indicated populations.
- FDA strongly encourages the enrollment of populations most affected by COVID-19, specifically racial and ethnic minorities.
- Evaluation of vaccine safety and efficacy in late phase clinical development in adults should include adequate representation of elderly individuals and individuals with medical comorbidities.
- FDA encourages vaccine developers to consider early in their development programs data that might support inclusion of pregnant women and women of childbearing potential who are not actively avoiding pregnancy in prelicensure clinical trials
That is why the surgeon general (a black man, for the record) and others mentioned it before, why the companies had to invest additional resources to address the issue in vaccine trials, and why it has historically been recognised as one of the challenges in vaccine trials. Minorities are by definition less present in the population, and if you add on top their additional vaccine hesitancy and their acute distrust of being a guinea pig, there have been occasions when that section of the population wasn't properly studied, and there are reasons to believe that leads to worse health outcomes. If you accept the principle that not all treatments respond equally to all sections of society, then you accept the premise that certain sections of society should be given particular attention to. And the medical community don't care about the ongoing political movement to disregard race as a relevant characteristic, they just look at the data and act accordingly.